![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 6
Zeitschriftenartikel
Paller, Amy S.; Siegfried, Elaine C.; Cork, Michael J.; Wollenberg, Andreas; Arkwright, Peter D.; Gonzalez, Mercedes E.; Lockshin, Benjamin; Chen, Zhen; Bansal, Ashish; Levit, Noah A. und Prescilla, Randy
(2022):
Laboratory Safety from a Randomized 16-Week Phase III Study of Dupilumab in Children Aged 6 Months to 5 Years with Moderate-to-Severe Atopic Dermatitis.
In: Pediatric Drugs, Bd. 25, Nr. 1: S. 67-77
Paller, Amy S.; Simpson, Eric L.; Siegfried, Elaine C.; Cork, Michael J.; Wollenberg, Andreas; Arkwright, Peter D.; Soong, Weily; Gonzalez, Mercedes E.; Schneider, Lynda C.; Sidbury, Robert; Lockshin, Benjamin; Meltzer, Steven; Wang, Zhixiao; Mannent, Leda P.; Amin, Nikhil; Sun, Yiping; Laws, Elizabeth; Akinlade, Bolanle; Dillon, Myles; Kosloski, Matthew P.; Kamal, Mohamed A.; Dubost-Brama, Ariane; Patel, Naimish; Weinreich, David M.; Yancopoulos, George D.; O'Malley, John T. und Bansal, Ashish
(2022):
Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis: a randomised, double-blind, placebo-controlled, phase 3 trial.
In: Lancet, Bd. 400, Nr. 10356: S. 908-919
Paller, Amy S.; Beck, Lisa A.; Blauvelt, Andrew; Siegfried, Elaine C.; Cork, Michael J.; Wollenberg, Andreas; Chen, Zhen; Khokhar, Faisal A.; Vakil, Jignesh; Zhang, Annie; Bansal, Ashish und Cyr, Sonya L.
(2022):
Infections in children and adolescents treated with dupilumab in pediatric clinical trials for atopic dermatitis-A pooled analysis of trial data.
In: Pediatric Dermatology, Bd. 39, Nr. 2: S. 187-196
Paller, Amy S.; Wollenberg, Andreas; Siegfried, Elaine; Thaci, Diamant; Cork, Michael J.; Arkwright, Peter D.; Gooderham, Melinda; Sun, Xian; O'Malley, John T.; Khokhar, Faisal A.; Vakil, Jignesh; Bansal, Ashish; Rosner, Karli; Shumel, Brad und Levit, Noah A.
(2021):
Laboratory Safety of Dupilumab in Patients Aged 6-11 Years with Severe Atopic Dermatitis: Results from a Phase III Clinical Trial.
In: Pediatric Drugs, Bd. 23, Nr. 5: S. 515-527
Simpson, Eric L.; Paller, Amy S.; Siegfried, Elaine C.; Thaci, Diamant; Wollenberg, Andreas; Cork, Michael J.; Marcoux, Danielle; Huang, Rui; Chen, Zhen; Rossi, Ana B.; Shumel, Brad; Sierka, Debra und Bansal, Ashish
(2021):
Dupilumab Demonstrates Rapid and Consistent Improvement in Extent and Signs of Atopic Dermatitis Across All Anatomical Regions in Pediatric Patients 6 Years of Age and Older.
In: Dermatology and Therapy, Bd. 11, Nr. 5: S. 1643-1656
Paller, Amy S.; Siegfried, Elaine C.; Thaci, Diamant; Wollenberg, Andreas; Cork, Michael J.; Arkwright, Peter D.; Gooderham, Melinda; Beck, Lisa A.; Boguniewicz, Mark; Sher, Lawrence; Weisman, Jamie; O'Malley, John T.; Patel, Naimish; Hardin, Megan; Graham, Neil M. H.; Ruddy, Marcella; Sun, Xian; Davis, John D.; Kamal, Mohamed A.; Khokhar, Faisal A.; Weinreich, David M.; Yancopoulos, George D.; Beazley, Bethany; Bansal, Ashish und Shumel, Brad
(2020):
Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: A randomized, double-blinded, placebo-controlled phase 3 trial.
In: Journal of the American Academy of Dermatology, Bd. 83, Nr. 5: S. 1282-1293